Where is the live CopyMark page for USPTO serial 77740174?

The live record is at https://getcopymark.com/trademark/77740174. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns TEV-TUXIMAB?

According to the public USPTO record for serial number 77740174, the listed owner(s) include: TEVA Pharmaceutical Industries Ltd., TEVA Pharmaceutical Industries Ltd..

What is USPTO serial number 77740174?

Serial number 77740174 is the USPTO application identifier for the mark TEV-TUXIMAB. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover TEV-TUXIMAB?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

4.9/5

USPTO serial 77740174

TEV-TUXIMAB

Q: What is the current status of TEV-TUXIMAB?

TEV-TUXIMAB (77740174) currently shows USPTO status code 605 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Reviewed by CopyMark Law Group

Status 605

Filing date: May 19, 2009
Status date: Feb 2, 2010
Registration date: —
Examiner: ERVIN, INGA
Law office: OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TEV-TUXIMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa A. Pieroni

LISA A. PIERONI KIRSCHSTEIN, ISRAEL, SCHIFFMILLER & PIER425 5TH AVE FL 5NEW YORK, NY 10016-2223UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations containing rituximab	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 2, 2010	MAB5	ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	—
Feb 2, 2010	ABN5	ABANDONMENT - AFTER PUBLICATION	—
Jan 25, 2010	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Oct 27, 2009	ETOF	EXTENSION OF TIME TO OPPOSE RECEIVED	—
Sep 29, 2009	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2009	NPUB	NOTICE OF PUBLICATION	—
Aug 22, 2009	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Aug 22, 2009	ALIE	ASSIGNED TO LIE	—
Aug 18, 2009	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Aug 18, 2009	DOCK	ASSIGNED TO EXAMINER	—
May 23, 2009	MPMK	NOTICE OF PSEUDO MARK MAILED	—
May 22, 2009	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
May 22, 2009	NWAP	NEW APPLICATION ENTERED	—